|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-3-12
|
|
pubmed:abstractText |
Somatostatin receptor expression, which was not a previously described marker for Hürthle cell cancer of the thyroid, was demonstrated by in vivo imaging with (111)In-pentetreotide in three patients. This phenomenon not only adds another imaging technique to the nuclear medicine armamentarium for detecting recurrent and metastatic cancer in patients with Hürthle cell cancer but also opens up an alternative therapeutic avenue with somatostatin analogs or their radiolabeled compounds.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
243-5
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9476928-Adenoma, Oxyphilic,
pubmed-meshheading:9476928-Aged,
pubmed-meshheading:9476928-Humans,
pubmed-meshheading:9476928-Indium Radioisotopes,
pubmed-meshheading:9476928-Male,
pubmed-meshheading:9476928-Middle Aged,
pubmed-meshheading:9476928-Octreotide,
pubmed-meshheading:9476928-Pentetic Acid,
pubmed-meshheading:9476928-Radiopharmaceuticals,
pubmed-meshheading:9476928-Receptors, Somatostatin,
pubmed-meshheading:9476928-Thyroid Neoplasms
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Somatostatin receptor expression in Hürthle cell cancer of the thyroid.
|
|
pubmed:affiliation |
Division of Nuclear Medicine, University of Miami School of Medicine Department, Florida, USA.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
